Pemomab (Pembrolizumab) 100mg/4mL | Affordable PD-1 Inhibitor Biosimilar | GLT

What is Pemomab (Pembrolizumab)?

Pemomab is a biosimilar of pembrolizumab, a humanized monoclonal antibody that targets the PD-1 receptor on T-cells. By blocking the PD-1 immune checkpoint, it releases the brake on the immune system and enables T-cells to recognize and attack cancer cells. Pemomab offers the same PD-1 inhibition mechanism at a more accessible price point.

What is Pemomab Used For?

Pemomab (pembrolizumab biosimilar) is used for the treatment of multiple cancers where PD-1 inhibition is indicated, including non-small cell lung cancer (NSCLC), melanoma, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, urothelial carcinoma, gastric cancer, and microsatellite instability-high (MSI-H) solid tumors.

How Does Pembrolizumab Work?

PD-1 is a checkpoint protein on T-cells that normally keeps the immune response in check. Cancer cells often exploit PD-1 by expressing PD-L1, which binds to PD-1 and switches off the T-cell attack. Pembrolizumab binds to PD-1, preventing this interaction and restoring the immune system's ability to detect and destroy tumor cells.

Dosage & Administration

The recommended dose is 200 mg every 3 weeks or 400 mg every 6 weeks, administered as an intravenous infusion over 30 minutes. Dosing must be determined by the treating oncologist.

Common Side Effects

The most common adverse reactions include fatigue, decreased appetite, pruritus, rash, diarrhea, nausea, and musculoskeletal pain. Immune-related adverse events such as pneumonitis, colitis, hepatitis, and endocrinopathies may occur and require prompt medical attention.

Storage

Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze. Do not shake.

Why Choose the GLT?

Pemomab offers a cost-effective alternative to the reference pembrolizumab product while providing the same mechanism of action. Key advantages include:

• Affordable pricing — significantly lower than reference brands
• Same PD-1 inhibition mechanism as reference pembrolizumab
• Manufactured by Ziska Pharmaceuticals, an established Bangladesh manufacturer
• Global export by Hong Kong-licensed wholesaler with full documentation

Quality Assurance

All Pemomab supplied by GIVE LIFE TIME LIMITED is sourced directly from Ziska Pharmaceuticals with full batch traceability and Certificate of Analysis (COA). Every shipment includes export-ready documentation: commercial invoice, packing list, and Certificate of Origin.

How to Order

To request pricing and place an order, please follow these steps:

1. Send your prescription or case file via WhatsApp or email — reviewed within 24 hours
2. Receive a formal quotation with pricing, availability, and shipping options
3. Confirm and arrange payment via bank transfer or PayPal
4. Ship globally with full export documentation and tracking

Send your prescription / case file now: WhatsApp: +86 15234153837

Frequently Asked Questions

Is Pemomab the same as Keytruda?

Pemomab is a biosimilar of pembrolizumab (the active ingredient in Keytruda). It contains the same active substance and works through the same PD-1 inhibition mechanism, but is manufactured by Ziska Pharmaceuticals rather than Merck.

Is a prescription required?

Yes. Pemomab is a prescription-only medicine. A valid prescription from a licensed oncologist is required.

How long does international shipping take?

Most orders are dispatched within 3-5 business days after payment confirmation, with delivery times of 7-14 business days depending on destination.

Do you ship with cold-chain logistics?

Yes. Pemomab requires temperature-controlled shipping (2-8°C) and is packed in validated cold-chain packaging.